Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred K Cheung

Showing results (11-20 of 262) with videos related to

Pageof 27
Sort By:
Kidney International|May 21, 2022
The authors replyJohannes F E Mann, Alfred K Cheung
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 20, 2007
Pathogenesis and local drug delivery for prevention of vascular access stenosisAlfred K Cheung, Christi Terry, Li Li
Blood Purification|January 23, 2010
Special considerations for antihypertensive agents in dialysis patientsJosep Redon, Fernando Martinez, Alfred K Cheung
Thrombosis Research|June 19, 2016
Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosisChristi M Terry, Yuxia He, Alfred K Cheung
Seminars in Nephrology|March 26, 2005
Dialyzer membranes as determinants of the adequacy of dialysisMadhukar Chelamcharla, John K Leypoldt, Alfred K Cheung
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2007
Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft modelTadashi Kuji, Takahisa Masaki, Li Li, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2006
Hemodialysis vascular access dysfunction: a cellular and molecular viewpointPrabir Roy-Chaudhury, Vikas P Sukhatme, Alfred K Cheung
American Journal of Translational Research|July 16, 2015
Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?Guangyu Zhou, Xia Liu, Alfred K Cheung, et al.
Clinical Science (London, England : 1979)|November 8, 2013
Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammationGuangyu Zhou, Alfred K Cheung, Xia Liu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 28, 2010
Blood pressure control in type 2 diabetes mellitusTara I Chang, Alfred K Cheung, Glenn M Chertow
Pageof 27

Showing results (11-20 of 262) with videos related to

Sort By:
Pageof 27
Kidney International|May 21, 2022
The authors replyJohannes F E Mann, Alfred K Cheung
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 20, 2007
Pathogenesis and local drug delivery for prevention of vascular access stenosisAlfred K Cheung, Christi Terry, Li Li
Blood Purification|January 23, 2010
Special considerations for antihypertensive agents in dialysis patientsJosep Redon, Fernando Martinez, Alfred K Cheung
Thrombosis Research|June 19, 2016
Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosisChristi M Terry, Yuxia He, Alfred K Cheung
Seminars in Nephrology|March 26, 2005
Dialyzer membranes as determinants of the adequacy of dialysisMadhukar Chelamcharla, John K Leypoldt, Alfred K Cheung
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2007
Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft modelTadashi Kuji, Takahisa Masaki, Li Li, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2006
Hemodialysis vascular access dysfunction: a cellular and molecular viewpointPrabir Roy-Chaudhury, Vikas P Sukhatme, Alfred K Cheung
American Journal of Translational Research|July 16, 2015
Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?Guangyu Zhou, Xia Liu, Alfred K Cheung, et al.
Clinical Science (London, England : 1979)|November 8, 2013
Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammationGuangyu Zhou, Alfred K Cheung, Xia Liu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 28, 2010
Blood pressure control in type 2 diabetes mellitusTara I Chang, Alfred K Cheung, Glenn M Chertow
Pageof 27